（原标题：A股"隔膜龙头"，并购大动作！股票下周一复牌） 中科华联成立于2011年，是专业研发、生产和销售湿法锂离子电池隔膜整套生产装备、其他薄膜等高分 子材料生产设备及隔膜制品的高新技术企业，主要客户为锂电池和锂电池隔膜厂商。 据悉，恩捷股份旨在通过本次收购实现产业链上游延伸，构建"设备+材料"的协同优势。公告指出，本 次交易完成后，恩捷股份将实现从隔膜装备到隔膜产品的产业链垂直整合，通过自身在锂电池隔膜领域 的技术优势与中科华联先进装备制造能力的深度融合，进一步释放产能潜力，在提产降本的同时实现产 业链协同与发展共赢。 "隔膜龙头"恩捷股份拟收购中科华联100%股份，股票复牌。 恩捷股份12月12日公告，拟通过发行股份的方式向郅立鹏、青岛众智达、陈继朝、杨波、袁军等共63名 交易对方购买其合计持有的青岛中科华联新材料股份有限公司（简称"中科华联"）100%的股份，并募 集配套资金。 截至目前，中科华联的审计和评估工作尚未完成，本次交易的具体交易价格尚未确定。恩捷股份股票将 于12月15日（星期一）开市起复牌。 2025年，恩捷股份相继推出高强度基膜、高浸润基膜以及阻燃隔膜等创新产品。同时，也已提前布局固 ...

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, aiming to enhance its production capabilities in the lithium battery separator market while addressing operational pressures and competition in the industry [1][3]. Group 1: Acquisition Details - Enjie intends to issue shares to 63 parties to purchase all shares of Zhongke Hualian and raise matching funds not exceeding 100% of the transaction price [1]. - The share issuance price is set at 34.38 yuan per share, representing a 37.9% discount from the last trading price before suspension [1]. - The specific transaction price is yet to be determined as the audit and evaluation of the target company are still ongoing [1]. Group 2: Zhongke Hualian's Role - Zhongke Hualian is one of the few manufacturers capable of providing complete wet lithium battery separator production lines and is a key supplier for Enjie [2]. - The company has established production bases with a total capacity expected to reach 30 billion square meters by the end of 2026, with plans for further expansion [2]. - Major clients include leading battery manufacturers such as CATL and BYD, with over 80% of its revenue coming from a few key customers, indicating a reliance risk [2]. Group 3: Impact on Enjie - The acquisition will allow Enjie to utilize Zhongke Hualian's production equipment and technology to produce high-performance separators, potentially lowering production costs [2][3]. - Enjie aims to quickly initiate equipment manufacturing and separator production line construction post-acquisition, enhancing its operational efficiency [3]. - The company is also looking to expand its overseas production capabilities to mitigate supply chain risks [3]. Group 4: Financial Performance and Risks - Enjie has faced significant financial challenges, reporting a 36.84% decline in net profit in 2023 and a projected net loss of 5.56 billion yuan in 2024, marking its first loss since going public [3]. - The company reported a revenue increase of 27.85% in the first three quarters of 2025, but net profit showed a loss of 86.32 million yuan, indicating a trend of increasing revenue without corresponding profit [4]. - As of September 30, 2025, Enjie had significant debt levels of 156 billion yuan against cash reserves of only 24.49 billion yuan, highlighting short-term repayment pressures [4].

Group 1 - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, aiming to extend its upstream supply chain and achieve vertical integration from separator equipment to separator products [2] - Zhongke Hualian, established in 2011, specializes in the R&D, production, and sales of wet lithium-ion battery separator production equipment and other polymer material production equipment, primarily serving lithium battery manufacturers [2] - The acquisition is expected to enhance Enjie's production capacity and cost efficiency while fostering collaborative development within the supply chain [2] Group 2 - Enjie Co., Ltd. is a leading global supplier of lithium battery separators, with its core products primarily used in new energy vehicle batteries, 3C products, and energy storage, maintaining the top market share for several consecutive years [3] - The company has established itself within the supply chains of major lithium battery manufacturers, including CATL, BYD, and Panasonic, indicating strong market presence and customer relationships [3] - Enjie plans to launch innovative products such as high-strength base films and flame-retardant separators by 2025, while also advancing into the solid-state battery sector [3] Group 3 - The lithium battery separator industry is experiencing a trend of mergers and acquisitions to optimize the supply chain, with major players like CATL and Zhongxin Innovation moving upstream into lithium salt production [3] - Enjie has noted a slowdown in new separator production capacity due to previous oversupply, which is expected to improve the supply-demand balance in the industry [4] - The company aims to enhance its competitiveness by improving product performance, optimizing structure, and increasing service quality [4]

Group 1: Economic Indicators - As of the end of November, the total social financing scale reached 440.07 trillion yuan, with a year-on-year growth of 8.5% [3][4] - The broad money supply (M2) stood at 336.99 trillion yuan, reflecting a year-on-year increase of 8.0% [3][4] - In the first eleven months, the cumulative increase in social financing was 33.39 trillion yuan, which is 3.99 trillion yuan more than the same period last year [3] Group 2: Monetary Policy - The People's Bank of China emphasized the continuation of a moderately loose monetary policy, aiming to support stable economic growth and reasonable price recovery [4] - The bank plans to utilize various monetary policy tools flexibly, including reserve requirement ratio cuts and interest rate reductions, to maintain ample liquidity [4] Group 3: Industry Developments - The China Photovoltaic Industry Association announced the establishment of a "polysilicon capacity integration acquisition platform," aimed at addressing intense competition within the photovoltaic sector [4] - The China Securities Investment Fund Industry Association issued a draft regulation to standardize the sales behavior of publicly offered securities investment funds, covering various aspects such as promotional activities and performance assessments [4] Group 4: Company News - *ST Bosen announced the termination of a major asset restructuring due to failure to reach agreement on key terms [6] - Chip Origin Technology also decided to terminate its major asset restructuring transaction to protect shareholder interests [6] - More Thread plans to invest 7.5 billion yuan of idle fundraising in safe, liquid financial products [6] - Renfu Pharmaceutical received a notice of administrative penalty for false financial reporting, leading to a temporary suspension of its stock [7] - China High-Tech announced a potential change in control due to the transfer of shares by its major shareholder [8]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002812股票简称：恩捷股份 公告编号：2025-200 经全体董事表决，形成决议如下： （一）审议通过《关于公司发行股份购买资产并募集配套资金符合相关法律法规之规定的议案》 公司拟通过发行股份方式向郅立鹏、青岛众智达投资有限公司、陈继朝、杨波、袁军等交易对方购买其 所持有的青岛中科华联新材料股份有限公司（以下简称"中科华联"）100%的股份，并拟向不超过35名 符合条件的特定对象发行股份募集配套资金（以下简称"本次交易"）。 根据《公司法》《中华人民共和国证券法》（以下简称"《证券法》"）《上市公司重大资产重组管理办 法》《上市公司证券发行注册管理办法》《上市公司监管指引第9号一一上市公司筹划和实施重大资产 重组的监管要求》等法律、行政法规及规范性文件的有关规定，经对公司实际情况及相关事项进行自查 及论证后，认为本次交易符合上述法律、行政法规及规范性文件的规定。 云南恩捷新材料股份有限公司 第五届董事会第四十九次会议决议公告 本公司及全体董事保证本公告内容真实、准确和完整，没有虚假记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 云南恩捷新 ...

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, aiming to enhance its competitiveness in the lithium battery separator industry during a growth phase [1][4]. Group 1: Acquisition Details - The share issuance price for the acquisition is set at 34.38 yuan per share, which is not less than 80% of the average trading price over the previous 120 trading days [2][3]. - The specific transaction price for the acquisition is yet to be determined as the audit and evaluation of Zhongke Hualian are still ongoing [3]. - Enjie plans to raise matching funds through the issuance of shares to no more than 35 qualified investors, with the total amount not exceeding 100% of the transaction price [3]. Group 2: Industry Context - Enjie, as a leading supplier of lithium battery separators, aims to integrate Zhongke Hualian's advantages in separator equipment and products to reduce supply chain risks and enhance overall competitiveness [4]. - The lithium battery separator industry is currently experiencing a high growth phase, with Enjie’s chairman expressing optimism about sustained growth in the coming years [1][4]. Group 3: Financial Performance - As of September 30, 2025, Enjie reported total assets of 48 billion yuan and equity attributable to shareholders of 24.78 billion yuan [5][9]. - For the first three quarters of 2025, Enjie’s net profit was 2.53 billion yuan, while Zhongke Hualian reported net losses of 824.31 million yuan, 293 million yuan, and 190 million yuan for 2023, 2024, and the first three quarters of 2025, respectively [5][7].

Company Announcements - Moer Thread plans to use 7.5 billion yuan of idle raised funds for cash management, investing in safe and liquid principal-protected products [2] - Chipone Technology has terminated the acquisition of 97% equity in Chipwise [3] - Renfu Pharmaceutical's stock will be subject to risk warning and renamed ST Renfu due to false financial disclosures in its annual report [3] - Enjie Co., Ltd. intends to acquire 100% of Zhongke Hualian's shares, with stock resuming trading on December 15 [3] Investments & Contracts - Chipone Technology plans to jointly invest in TianSui Chip and acquire control of Zhudian Semiconductor [8] - Jiangsu Guoxin's subsidiary has officially put a 1 million kilowatt unit into operation [17] - Zhongyuan Shipping has signed contracts for the construction of 19 vessels, with a total value of 7.882 billion yuan [18] Financing & Capital Increase - Tiens Wind Power plans to raise no more than 1.95 billion yuan through a private placement for the expansion of its new energy equipment manufacturing base [18] - Chang'an Automobile's subsidiary, Chang'an Technology, plans to increase capital by 600 million yuan, aiming to hold a 75% stake post-increase [10] - Tiankang Biological intends to acquire 51% of Qiangdu Livestock for 1.275 billion yuan, enhancing its feed technology and animal health systems [11] Shareholder Changes - Xicai Testing's controlling shareholder plans to transfer 4.22 million shares at a price of 48.59 yuan per share [17] - Xicheng Science's shareholder plans to reduce holdings by no more than 1% [16] Other Developments - Huaying Technology has received a final judgment to be compensated 3.029 billion yuan, which is expected to positively impact its operations [5] - Fushik Holdings will pay up to 1.35 million yuan in economic compensation to departing employees [21]

Group 1 - Enjie Co., Ltd. plans to acquire 100% of Zhongke Hualian New Materials Co., Ltd. through a share issuance, with trading resuming on December 15 [1] - The share issuance price for the acquisition is set at 34.38 yuan per share, which is not less than 80% of the average trading price over the previous 120 trading days [2] - Enjie aims to enhance its competitive edge in the lithium battery separator industry by integrating Zhongke Hualian's advantages in separator equipment and products [3] Group 2 - Enjie reported a revenue of 3.78 billion yuan for Q3 2025, reflecting a year-on-year growth of 40.98% [3] - As of September 30, 2025, Zhongke Hualian's total assets were 4.478 billion yuan, with a net profit attributable to shareholders of -824.31 million yuan for 2023 [3][5] - Enjie's total assets reached 48 billion yuan as of September 30, 2025, with a net profit attributable to shareholders of 2.527 billion yuan for 2023 [5][8]

Group 1: 恒瑞医药 - Company announced that its subsidiary received approval for clinical trials of HRS9531 injection, a novel dual agonist targeting GIPR and GLP-1R, aimed at treating metabolic dysfunction-related fatty liver disease (MASH) [1] - HRS9531 injection is expected to improve blood sugar levels and reduce weight by regulating glucose and lipid metabolism, suppressing appetite, and enhancing insulin sensitivity [1] - There are currently no similar drugs approved globally for the MASH indication, and the total R&D investment for HRS9531 has reached approximately 519 million yuan [1] Group 2: 青岛港 - Company announced the termination of its cash acquisition of 100% equity in Rizhao Port Oil Products Terminal Co., Ltd. and 50% equity in Rizhao Shihua Oil Terminal Co., Ltd. due to significant impacts from Rizhao Shihua being listed on the U.S. Specially Designated Nationals list [2] - The termination agreement was signed on December 12, 2025, and will not incur any breach of contract or other liabilities, nor will it adversely affect the company's operations or financial status [2] Group 3: 隆盛科技 - Company plans to invest approximately 350 million yuan to establish a humanoid intelligent robot innovation center in Wuxi, with a focus on R&D and industrialization of humanoid robots [3] - The project will involve a total investment of about 350 million yuan, with the company covering around 200 million yuan for land and construction, while its subsidiary will invest approximately 150 million yuan for the center's operation [3] Group 4: *ST沪科 - Company received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws [4] - The company stated that its production and operations are normal and that the investigation will not have a significant impact on its management [4] Group 5: 永鼎股份 - Company clarified that it does not directly manufacture controllable nuclear fusion devices, despite being listed as a related concept stock [5] - The revenue from its subsidiary related to this area accounts for less than 1% of the company's total revenue and is currently operating at a loss [5] - The controlling shareholder reduced its stake by 1.336 million shares during a period of abnormal stock trading [5] Group 6: 亚翔集成 - Company announced that its shareholder EVER CREATIVE reduced its stake by 414,000 shares on December 11, 2025, amid significant stock price fluctuations [6] - The stock experienced a cumulative price deviation exceeding 20% over two consecutive trading days [6] Group 7: 恩捷股份 - Company plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance and will resume trading on December 15 [8] Group 8: 芯原股份 - Company announced the termination of its plan to acquire 97% of Chipwise Technology due to discrepancies between the management's core demands and market conditions [9] - The decision was made to protect the interests of the company and its shareholders [9]

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, aiming to enhance its product matrix and reduce production costs [1][3]. Group 1: Company Overview - Enjie Co., Ltd. is a leading supplier of lithium battery separators, primarily serving the electric vehicle battery manufacturing sector, 3C products, and energy storage [2]. - The company has established a strong presence in the global supply chain of major lithium battery manufacturers, including CATL, BYD, and Panasonic, maintaining the largest market share for several consecutive years [2]. Group 2: Acquisition Details - The acquisition involves issuing shares at a price of 34.38 yuan per share, with the specific transaction price yet to be determined as the audit and evaluation of the target company are still ongoing [1]. - The acquisition is seen as a strategic move to transition from product competition to a full supply chain system competition, indicating a shift in the industry towards higher concentration [3]. Group 3: Strategic Implications - The transaction will allow Enjie to utilize Zhongke Hualian's separator production equipment and technology, enabling the production of high-performance separator products and reducing operational costs [3]. - The acquisition is expected to facilitate overseas production line construction and mitigate supply chain risks, while also complementing the product matrix with Zhongke Hualian's Blue Ketu separator brand [3]. Group 4: Market Context - Recent communications from the company indicate that separator prices are influenced by supply and demand dynamics, with expectations for gradual recovery in pricing due to cautious industry expansion and increasing downstream demand [3]. - Prior to the acquisition announcement, Enjie's stock had a closing price of 55.35 yuan per share, with a total market capitalization of 54.37 billion yuan, and a cumulative increase of 14.08% over the previous 20 trading days [4].